Drug utilization review

Last updated
Drug Utilization Review
TypePharmaceuticals policy
Established1969
Area sizemajor in Koern[ clarification needed ] and America
Establishmentsprivate pharmaceutical management company

Drug utilization review refers to a review of prescribing, dispensing, administering and ingesting of medication. [1] This authorized, structured and ongoing review is related to pharmacy benefit managers. [2] Drug use/ utilization evaluation and medication utilization evaluations are the same as drug utilization review. [3]

Contents

With the development of society and the economy, the costs of health care grows rapidly, and this becomes a burden on the worldwide health protection system. [4] Aging populations, a changing disease spectrum, and the progress and change in technology of health care become the major problems which lead to increasing of health care costs. [4] Then, how to use drug utilization evaluation and drug economy evaluation to improve and optimize the allocation of medical and health resources is a major problem faced by many countries. [4]

Drug utilization reviews will help ensure that drugs are used appropriately (for individual patients). In the drug utilization review, medicine and health history including all phases of dispensing for a patient is exactly listed. [1] Also, this review is designed to attempt to attain proper decision making therapeutically and gain a positive outcome for the patient. [1] If treatment is considered inappropriate, it will be necessary to intervene with providers or patients to optimize medication. [5] Then, especially in the community medicine setting, Drug utilization review plays a key role for pharmacist. [6] In addition, The World Health Organization (WHO) regards drug utilization as 4 phases of drugs in society. These four phases are marketing, distribution, prescription and usage. [3]

History

The doctor prescribes medication for patients USMC-12633.jpg
The doctor prescribes medication for patients

Drug utilization review originated from the North America. However, in the recent years, other countries do more research and studies about drug utilization review. [7]

Some developments are regarded as important promoters for the appearance of drug utilization review. One factor is the increasing coverage of insurance for medication dispensing in the 1970s and 1980s. This insurance decreased the cost of medication dispensing for the economic interest and create computer-based data of patient therapy information. [7] Another factor is that technical feasibility was improved in 1960s. [7]

The first document published related to drug utilization review was in 1969. Drug utilization review acted as a background paper written by the United States Department of Health, Education, and Welfare task force. This task force considered that drug utilization review was potential but this review should be evaluated and need valid evidence to put into effect. [7]

In 1970, Drug utilization review program was carried out by a private pharmaceutical management company. It focused on the cost of another program. [7]

By the mid-1970, many medical programs cooperate with private companies that providing drug utilization review. [7]

From 1985, hospitals in America are requested to use drug utilization review when using antibiotics. [7]

In community pharmacy Settings, Federal Law (OBRA-90) requires drug utilization review for patients receiving medication through Medicaid. [8] Then Drug utilization review was common in society.

Recognizing that Medicaid recipients faced similar risks in the 1980s, Congress provided for the ambulatory drug utilization review under the Omnibus Budget Reconciliation Act of 1990. It set up three relevant goals for a drug utilization review program. [9] They are as follows: (1) reducing hospitalizations due to adverse drug events, (2) preventing and detecting fraud and abuse, and (3) supporting evidence-based prescribing through communication with others through academic details (i.e., face-to-face educational outreach by authoritative professionals in the non-profit sector). [9]

Except goals mentioned above, there are still other goals of drug utilization review.

Other goals may include: [5]

a. Promoting optimal medication and ensure that medication meets current standards of care.

b. Developing guidelines (standards) for appropriate drug use

c. Assess the effectiveness of medication

d. Enhance accountability in drug use

e. Control medical expenses

f. Prevention of drug-related problems such as adverse drug reactions, treatment failure, overuse, under-use, incorrect dosage and use of over-the-counter drugs

g. Identify areas where health care providers may need further information and education. Once the main problem areas have been identified (from integrated data, health indicators, qualitative studies, other appropriate studies, and even recommendations from developing country committee members), appropriate systems can be established relatively quickly.

Three types of drug utilization review

Prospective

Prospective drug utilization review refers to assessing appropriate drug and decision making therapeutically before patients' medication are dispensed. [10] This prospective review is based on the history recording of the drug and medication. Then, practitioners could assess therapy for patients on the basis history recording. [11]

There are some issues addressed by this review: drug abuse clinically, alteration of drug dosage, drug–drug interaction, and drug-disease interaction. [1]

Measure and record the blood pressure for next therapy. Taking blood pressure (SC 191775), National Museum of Health and Medicine (5201016091).jpg
Measure and record the blood pressure for next therapy.

This review seems the best review over all three reviews because it is the closest option of the ideal. [11]

Concurrent

Concurrent drug utilization review refers to conducting the review concurrently with the process of dispensing medication for patients. [11] It means that the dispensing process will stop if a potential problem occurs and it is found by the review. [11]

There are some issues addressed by this review: alteration of drug dosage, drug–drug interaction, drug-disease interaction, patient prevention with the drug, and over-utilization and under utilization. [1]

However, there are still some problems in concurrent drug utilization review. The pharmacy of hospital and practitioners may not totally know the exact medications that patients normally use at home. Also, hospital and practitioners are not certain the document provided by patients is complete, and then this leads to some repeating test and medication. Thus, this review seems expensive and time-consuming. [11]

Retrospective

Retrospective drug utilization review refers to drug therapy review that after patients have got the medication. [10] The retrospective drug utilization review has a typical process. [12] This is a computer based review. Computer will show data which are in violation of the standard. The standard are the rules or expectations for the outcome comparing with. [12]

There are some issues addressed by this review: alteration of drug dosage, drug–drug interaction, drug-disease interaction, patient prevention with drug, over-utilization and under-utilization, drug abuse clinically, proper generic use, and false in drug dosage. [1]

However, there are still some problems in retrospective drug utilization review. If a problem occurs, practitioners are possible to prevent much worse results by ceasing the therapy during the next phase review. But if the problem is serious or toxic, then the harm is irretrievable and the worst result is death. [11]

Steps in conducting drug utilization review

These are the steps:

A doctor using computer-based data to review. Doctor reviewing pdq.jpg
A doctor using computer-based data to review.

a. Determine the scope and objectives of activities and quest approval. [5]

b. Structure of the standard or criteria and apply them. [7] (Standard and criteria must be valid.)

- uses: suitable for medicine, no contraindications

- selection: drugs that are appropriate for the clinical situation

- dosing: dose, treatment interval, and duration for specific indicators

- interactions: lack of interactions - drugs - drugs, drugs - foods, drug laboratories

- preparation: procedures for preparing medication delivery

- administration: administration steps, quantity distributed

- patient education: giving patients guidance on medications and specific diseases

- monitoring: clinical and laboratory

- results, such as: lower blood pressure, lower blood sugar, asthma attacks c. Data collection. [5]

d. Assess and analyze yield. [7]

e. Set up intervention strategies. [7]

- education

- preparation of drug order forms

- prescription restrictions

- change formula lists and/or manuals

- change standard treatment guidelines

- use another drug utilization review or continue with the current drug utilization review.


f. Re-apply standard or criteria to databases and revise standard or criteria as needed. [7]

Even though the model may be applied variously in various settings, major characteristics are the same during settings. [7]

Role and benefits of drug utilization review

Drug utilization review applies more and more in many aspects and areas. It is important for medication and mechanism to find the reasons and types of the variations and decrease the unfavorable and unsupportable variation. [9] Also, drug utilization review technology show the possibility to the elevated pharmacy therapy over the history recording of medication. [9] Drug utilization review helps pharmacists to evaluating the medication for patients. [3] Drug utilization review plays a key role in therapy and medication dispensing. It also helps improving the medication and drug dosage and provides feedback to hospital and practitioners for their therapy and their performance. [3] In addition, this Drug utilization review information may also encourage practitioners to modify and alter their normal habits in prescribing and then improve care. [3]

However, the real value of such a system seems to lie in a retrospective review of practice patterns in different patients and at different times, combined with targeted educational outreach programs. [13]

Medication use evaluation is beneficial to medical students and provides practice places. [14] It not only improves prescribing practices and ensures safety outcomes but also help students improve their medication therapy. [14]

Future of drug utilization review

Drug store of future (The drug store of the future) (4378797665).jpg
Drug store of future

According to reasonable research, prospective drug utilization review and retrospective drug utilization review program are not providing an improvement in the outcome of clinic within a basis of population. [7] In addition, there exist some major drug utilization review program problems including questions and validity in standards and highly unacceptable alert rates. [7] Furthermore, the knowledge base should be strengthened and improved.

The cost of non-optimal drug utilization is enormous and this was one of the reason that drug utilization review appears. [7] The development and research of the drug utilization review program are expected and need more creative methods. [7]

Furthermore, according to a research, some hospitals did not regard prospective and concurrent drug utilization review enablers such as CDSSs, PDCS, ICPS, PIS[ clarification needed ] detection capabilities as standard procedures or services, as did retrospective drug utilization review. These hospitals have great opportunities for improvement in their drug utilization review programs. [15]

Related Research Articles

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist is a healthcare professional who specializes in the preparation, dispensing, and management of medications and who provides pharmaceutical advice and guidance. Pharmacists often serve as primary care providers in the community, and may offer other services such as health screenings and immunizations.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Medical prescription</span> Health-care communication from a physician to a pharmacist

A prescription, often abbreviated or Rx, is a formal communication from a physician or other registered healthcare professional to a pharmacist, authorizing them to dispense a specific prescription drug for a specific patient. Historically, it was a physician's instruction to an apothecary listing the materials to be compounded into a treatment—the symbol ℞ comes from the first word of a medieval prescription, Latin recipere, that gave the list of the materials to be compounded.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

The Pharmaceutical Benefits Scheme (PBS) is a program of the Australian Government that subsidises prescription medication for Australian citizens and permanent residents, as well as international visitors covered by a reciprocal health care agreement. The PBS is separate to the Medicare Benefits Schedule, a list of health care services that can be claimed under Medicare, Australia's universal health care insurance scheme.

<span class="mw-page-title-main">Polypharmacy</span> Use of five or more medications daily

Polypharmacy (polypragmasia) is an umbrella term to describe the simultaneous use of multiple medicines by a patient for their conditions. The term polypharmacy is often defined as regularly taking five or more medicines but there is no standard definition and the term has also been used in the context of when a person is prescribed 2 or more medications at the same time. Polypharmacy may be the consequence of having multiple long-term conditions, also known as multimorbidity and is more common in people who are older. In some cases, an excessive number of medications at the same time is worrisome, especially for people who are older with many chronic health conditions, because this increases the risk of an adverse event in that population. In many cases, polypharmacy cannot be avoided, but 'appropriate polypharmacy' practices are encouraged to decrease the risk of adverse effects. Appropriate polypharmacy is defined as the practice of prescribing for a person who has multiple conditions or complex health needs by ensuring that medications prescribed are optimized and follow 'best evidence' practices.

A methadone clinic is a medical facility where medications for opioid use disorder (MOUD) are dispensed-—historically and most commonly methadone, although buprenorphine is also increasingly prescribed. Medically assisted drug therapy treatment is indicated in patients who are opioid-dependent or have a history of opioid dependence. Methadone is a schedule II (USA) opioid analgesic, that is also prescribed for pain management. It is a long-acting opioid that can delay the opioid withdrawal symptoms that patients experience from taking short-acting opioids, like heroin, and allow time for withdrawal management. In the United States, by law, patients must receive methadone under the supervision of a physician, and dispensed through an Opioid Treatment Program (OTP) certified by the Substance Abuse and Mental Health Services Administration and registered with the Drug Enforcement Administration.

Pharmacy and Therapeutics (P&T) is a committee at a hospital or a health insurance plan that decides which drugs will appear on that entity's drug formulary. The committee usually consists of healthcare providers involved in prescribing, dispensing, and administering medications, as well as administrators who evaluate medication use. They must weigh the costs and benefits of each drug and decide which ones provide the most efficacy per dollar. This is one aspect of pharmaceutical policy. P&T committees utilize an evidence-based approach to drive change within health systems/plans by changing existing policies and bringing up-to-date research to support medical decision-making.

<span class="mw-page-title-main">Compounding</span> Preparation of a custom medication

In the field of pharmacy, compounding is preparation of custom medications to fit unique needs of patients that cannot be met with mass-produced products. This may be done, for example, to provide medication in a form easier for a given patient to ingest, or to avoid a non-active ingredient a patient is allergic to, or to provide an exact dose that isn't otherwise available. This kind of patient-specific compounding, according to a prescriber's specifications, is referred to as "traditional" compounding. The nature of patient need for such customization can range from absolute necessity to individual optimality to even preference.

Many developing nations have developed national drug policies, a concept that has been actively promoted by the WHO. For example, the national drug policy for Indonesia drawn up in 1983 had the following objectives:

Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs, biologics, vaccines and natural health products.

<span class="mw-page-title-main">Clinical pharmacy</span> Branch of pharmacy for direct provision

Clinical pharmacy is the branch of pharmacy in which clinical pharmacists provide direct patient care that optimizes the use of medication and promotes health, wellness, and disease prevention. Clinical pharmacists care for patients in all health care settings but the clinical pharmacy movement initially began inside hospitals and clinics. Clinical pharmacists often work in collaboration with physicians, physician assistants, nurse practitioners, and other healthcare professionals. Clinical pharmacists can enter into a formal collaborative practice agreement with another healthcare provider, generally one or more physicians, that allows pharmacists to prescribe medications and order laboratory tests.

<span class="mw-page-title-main">Pharmacy (shop)</span> Shop that provides pharmaceutical drugs

A pharmacy is a retail shop which provides pharmaceutical drugs, among other products. At the pharmacy, a pharmacist oversees the fulfillment of medical prescriptions and is available to counsel patients about prescription and over-the-counter drugs or about health problems and wellness issues. A typical pharmacy would be in the commercial area of a community.

A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication. Today, the main function of a prescription formulary is to specify particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy. The development of prescription formularies is based on evaluations of efficacy, safety, and cost-effectiveness of drugs.

Electronic prescription is the computer-based electronic generation, transmission, and filling of a medical prescription, taking the place of paper and faxed prescriptions. E-prescribing allows a physician, physician assistant, pharmacist, or nurse practitioner to use digital prescription software to electronically transmit a new prescription or renewal authorization to a community or mail-order pharmacy. It outlines the ability to send error-free, accurate, and understandable prescriptions electronically from the healthcare provider to the pharmacy. E-prescribing is meant to reduce the risks associated with traditional prescription script writing. It is also one of the major reasons for the push for electronic medical records. By sharing medical prescription information, e-prescribing seeks to connect the patient's team of healthcare providers to facilitate knowledgeable decision making.

Medication therapy management, generally called medicine use review in the United Kingdom, is a service provided typically by pharmacists, medical affairs, and RWE scientists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. This includes providing education on the disease state and medications used to treat the disease state, ensuring that medicines are taken correctly, reducing waste due to unused medicines, looking for any side effects, and providing education on how to manage any side effects. The process that can be broken down into five steps: medication therapy review, personal medication record, medication-related action plan, intervention and or referral, and documentation and follow-up.

There are approximately 88,000 pharmacies in the United States. Over half are located within drug stores, grocery stores, hospitals, department stores, medical clinics, surgery clinics, universities, nursing homes, prisons, and other facilities. The remaining pharmacies are considered to be independent or privately owned. The top 25 pharmacy chain stores represent about 38,000 pharmacy locations in the U.S. and employ about 149,000 on-staff pharmacists. California has 8,015 pharmacies, the most of any state. Texas, Florida, New York, and Pennsylvania round out the top five states for pharmacy locations. Nationwide, the number of community pharmacies increased by 6.3% between 2007-2015, and the number of pharmacies per 10,000 people (2.11) did not change. However, the number of pharmacies per-capita varies substantially across counties, ranging from 0 to 13.6 per- 10,000 people in 2015.

Electronic Prescriptions for Controlled Substances (EPCS) was originally a proposal for the DEA to revise its regulations to provide practitioners with the option of writing electronic prescriptions for controlled substances. These regulations would also permit pharmacies to receive, dispense, and archive these electronic prescriptions. These proposed regulations would be an addition to, not a replacement of, the existing rule.

<span class="mw-page-title-main">Deprescribing</span> Process to taper or stop medications

Deprescribing is a process to taper or stop medications with the intention to achieve improved health outcomes by reducing exposure to medications that are potentially either harmful or no longer required. Deprescribing is important to consider with changing health and care goals over time, as well as polypharmacy and adverse effects. Deprescribing can improve adherence, cost, and health outcomes but may have adverse drug withdrawal effects. More specifically, deprescribing is the planned and supervised process of intentionally stopping a medication or reducing its dose to improve the person's health or reduce the risk of adverse side effects. Deprescribing is usually done because the drug may be causing harm, may no longer be helping the patient, or may be inappropriate for the individual patient's current situation. Deprescribing can help correct polypharmacy and prescription cascade.

<span class="mw-page-title-main">Drug labelling</span>

Drug labelling is also referred to as prescription labelling, is a written, printed or graphic matter upon any drugs or any of its container, or accompanying such a drug. Drug labels seek to identify drug contents and to state specific instructions or warnings for administration, storage and disposal. Since 1800s, legislation has been advocated to stipulate the formats of drug labelling due to the demand for an equitable trading platform, the need of identification of toxins and the awareness of public health. Variations in healthcare system, drug incidents and commercial utilization may attribute to different regional or national drug label requirements. Despite the advancement in drug labelling, medication errors are partly associated with undesirable drug label formatting.

References

  1. 1 2 3 4 5 6 Academy of Managed Care Pharmacy (2009). "Drug Utilization Review". amcp.org. Archived from the original on 2018-06-15. Retrieved 2019-05-12.
  2. Radloff, Tom; Jones, Steven (2007). "Patient Safety Through Drug Utilization Review". Benefits & Compensation Digest. 44 (7): 32–35.
  3. 1 2 3 4 5 Shimpi, R. D.; Salunkhe, P. S.; Bacaskar, S. R.; Laddha, G. P.; Kalam, A. A.; Patel, K.; Jain, S. S. (2012). "Drug utilization evaluation and prescription monitoring in asthmatic patients" (PDF). International Journal of Pharmacy and Biological Sciences. 2 (1): 117–122.
  4. 1 2 3 Zhao, C.; Yue, X. (2014-11-01). "The Importance and Use of Drug Utilization Review and Pharmacoeconomics". Value in Health. 17 (7): A733. doi: 10.1016/j.jval.2014.08.092 . ISSN   1098-3015. PMID   27202626.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 Holloway, Kathleen; Green, Terry (2003). "Drug and Therapeutics Committees - A Practical Guide" (PDF). Archived from the original (PDF) on June 5, 2010. Retrieved 2019-06-07.
  6. Mospan, Cortney M.; Alexander, Katelyn M. (2017). "Teaching drug utilization review skills via a simulated clinical decision making exercise". Currents in Pharmacy Teaching and Learning. 9 (2): 282–287. doi:10.1016/j.cptl.2016.11.021. PMID   29233414.
  7. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Hennessy, Sean; Soumerai, Stephen B.; Lipton, Helene Levens; Strom, Brian L. (2006-03-07), Strom, Brian L. (ed.), "Drug Utilization Review", Pharmacoepidemiology, John Wiley & Sons, Ltd, pp. 439–453, doi: 10.1002/9780470059876.ch29 , ISBN   9780470059876
  8. Carver, Niki; Dering Anderson, Allison M. (2019), "Drug Utilization Review (DUR)", StatPearls, StatPearls Publishing, PMID   28722899 , retrieved 2019-06-07
  9. 1 2 3 4 5 Lyles, Aln (2004). "The medicare drug benefit, prescribing variations, and drug utilization review". Clinical Therapeutics. 26 (1): 100–101. doi:10.1016/S0149-2918(04)90010-0. PMID   14996522.
  10. 1 2 Donohoe, Krista; Vaughn, L. Michelle; Patel, Jaykumar; Clare, Danielle M. (2014). "Medication use evaluation (MUE): A review of current literature and how-to guide for preceptors and pharmacy students". Currents in Pharmacy Teaching and Learning. 6 (5): 699–705. doi:10.1016/j.cptl.2014.05.005.
  11. 1 2 3 4 5 6 Wertheimer, A. I. (1988). "Quality control and drug utilization review". Pharmaceutisch Weekblad Scientific Edition. 10 (4): 154–157. doi:10.1007/BF01959424. ISSN   0167-6555. PMID   3174367. S2CID   42375315.
  12. 1 2 Hennessy, Sean (2003-09-17). "Retrospective Drug Utilization Review, Prescribing Errors, and Clinical Outcomes". JAMA. 290 (11): 1494–9. doi:10.1001/jama.290.11.1494. ISSN   0098-7484. PMID   13129990.
  13. Fulda, T. R. (1995-11-09). "Computer-Based Drug-Utilization Review". New England Journal of Medicine. 333 (19): 1290–1291. doi:10.1056/NEJM199511093331916. ISSN   0028-4793. PMID   7566017.
  14. 1 2 Lefkowitz-Ziegler, Pat (1989). "Drug Utilization Evaluation". Journal for Healthcare Quality. 11 (3): 16–17. doi:10.1111/j.1945-1474.1989.tb00413.x. ISSN   1062-2551. PMID   10318283. S2CID   39211259.
  15. AlJeraisy, M.; Alsultan, M.; Alkelya, M. (2016-05-01). "Drug Utilization Review Program in Saudi Hospitals: Enabling Factors and Implementation". Value in Health. 19 (3): A261. doi: 10.1016/j.jval.2016.03.796 . ISSN   1098-3015.